$SYM
Symbotic Inc.

2022 Q2 Form 10-Q Financial Statement

#000183724022000008 Filed on August 05, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2021 Q3 2021 Q2
Revenue $175.6M $91.70M $131.5M
YoY Change 33.51%
Cost Of Revenue $144.0M $83.90M $131.8M
YoY Change 9.24%
Gross Profit $31.54M $7.900M -$336.0K
YoY Change -9488.1%
Gross Profit Margin 17.97% 8.62% -0.26%
Selling, General & Admin $29.44M $18.40M $16.51M
YoY Change 78.31%
% of Gross Profit 93.31% 232.91%
Research & Development $35.14M $20.90M $20.93M
YoY Change 67.86%
% of Gross Profit 111.4% 264.56%
Depreciation & Amortization $1.300M $4.000M $1.300M
YoY Change 0.0%
% of Gross Profit 4.12% 50.63%
Operating Expenses $64.58M $39.30M $37.44M
YoY Change 72.47%
Operating Profit -$33.03M -$31.40M -$37.78M
YoY Change -12.57%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $156.0K $0.00 $7.000K
YoY Change 2128.57%
Pretax Income -$32.88M -$31.50M -$37.77M
YoY Change -12.96%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.314M -$155.2M -$37.77M
YoY Change -96.52%
Net Earnings / Revenue -0.75% -169.25% -28.73%
Basic Earnings Per Share -$0.03 $0.00
Diluted Earnings Per Share -$0.03 -$281.1K $0.00
COMMON SHARES
Basic Shares Outstanding 50.66M shares 0.000 shares
Diluted Shares Outstanding 50.66M shares 0.000 shares

Balance Sheet

Concept 2022 Q2 2021 Q3 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $411.7M
YoY Change
Cash & Equivalents $411.7M $156.6M $148.9M
Short-Term Investments
Other Short-Term Assets $50.00M
YoY Change
Inventory $127.0M $33.56M
Prepaid Expenses
Receivables $2.549M $63.37M
Other Receivables $0.00
Total Short-Term Assets $591.2M $260.4M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $20.51M $18.62M
YoY Change
Goodwill
YoY Change
Intangibles $800.0K $1.164M
YoY Change
Long-Term Investments
YoY Change
Other Assets $340.0K $334.0K
YoY Change
Total Long-Term Assets $21.65M $20.12M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $591.2M $260.4M
Total Long-Term Assets $21.65M $20.12M
Total Assets $612.8M $280.5M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $97.00M $28.02M
YoY Change
Accrued Expenses $51.08M $31.13M
YoY Change
Deferred Revenue $290.4M $259.4M
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $445.1M $337.0M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $5.983M $3.993M
YoY Change
Total Long-Term Liabilities $5.983M $3.993M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $445.1M $337.0M
Total Long-Term Liabilities $5.983M $3.993M
Total Liabilities $539.7M $557.5M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$1.281B -$1.155B
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.012M
YoY Change
Total Liabilities & Shareholders Equity $612.8M $280.5M
YoY Change

Cashflow Statement

Concept 2022 Q2 2021 Q3 2021 Q2
OPERATING ACTIVITIES
Net Income -$1.314M -$155.2M -$37.77M
YoY Change -96.52%
Depreciation, Depletion And Amortization $1.300M $4.000M $1.300M
YoY Change 0.0%
Cash From Operating Activities -$33.80M $13.60M $25.40M
YoY Change -233.07%
INVESTING ACTIVITIES
Capital Expenditures -$2.200M -$6.900M -$2.700M
YoY Change -18.52%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.200M -$6.900M -$2.700M
YoY Change -18.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 188.6M 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -33.80M 13.60M 25.40M
Cash From Investing Activities -2.200M -6.900M -2.700M
Cash From Financing Activities 188.6M 0.000 0.000
Net Change In Cash 152.6M 6.700M 22.70M
YoY Change 572.25%
FREE CASH FLOW
Cash From Operating Activities -$33.80M $13.60M $25.40M
Capital Expenditures -$2.200M -$6.900M -$2.700M
Free Cash Flow -$31.60M $20.50M $28.10M
YoY Change -212.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001837240
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-24
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-25
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40175
dei Entity Registrant Name
EntityRegistrantName
SYMBOTIC INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1572401
dei Entity Address Address Line1
EntityAddressAddressLine1
200 Research Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Wilmington
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01887
dei City Area Code
CityAreaCode
978
dei Local Phone Number
LocalPhoneNumber
284-2800
dei Security12b Title
Security12bTitle
Class A common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
SYM
sym Convertible Securities Conversion Period
ConvertibleSecuritiesConversionPeriod
P7Y
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
411662000 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156634000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2549000 usd
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
63370000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
126985000 usd
CY2021Q3 us-gaap Inventory Net
InventoryNet
33561000 usd
CY2022Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
550000 usd
CY2021Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
489000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
49435000 usd
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6366000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
591181000 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
260420000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
42858000 usd
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
37177000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22348000 usd
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18560000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20510000 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18617000 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
800000 usd
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1164000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
340000 usd
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
334000 usd
CY2022Q2 us-gaap Assets
Assets
612831000 usd
CY2021Q3 us-gaap Assets
Assets
280535000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
96995000 usd
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
28018000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
51081000 usd
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31131000 usd
CY2022Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
6625000 usd
CY2021Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
18405000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
290406000 usd
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
259418000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
445107000 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
336972000 usd
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
88613000 usd
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
216538000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5983000 usd
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3993000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
539703000 usd
CY2021Q3 us-gaap Liabilities
Liabilities
557503000 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q2 us-gaap Common Unit Authorized
CommonUnitAuthorized
0 shares
CY2022Q2 us-gaap Common Unit Issued
CommonUnitIssued
0 shares
CY2022Q2 us-gaap Common Unit Outstanding
CommonUnitOutstanding
0 shares
CY2021Q3 us-gaap Common Unit Authorized
CommonUnitAuthorized
7071424 shares
CY2021Q3 us-gaap Common Unit Issued
CommonUnitIssued
5997632 shares
CY2021Q3 us-gaap Common Unit Outstanding
CommonUnitOutstanding
5997632 shares
CY2022Q2 us-gaap Members Capital
MembersCapital
0 usd
CY2021Q3 us-gaap Members Capital
MembersCapital
16809000 usd
CY2022Q2 us-gaap Other Additional Capital
OtherAdditionalCapital
58126000 usd
CY2021Q3 us-gaap Other Additional Capital
OtherAdditionalCapital
26999000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1231992000 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1281020000 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1154944000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2139000 usd
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2092000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
7012000 usd
CY2021Q3 us-gaap Members Equity
MembersEquity
-1113228000 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
66116000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
73128000 usd
CY2021Q3 us-gaap Members Equity
MembersEquity
-1113228000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
612831000 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
280535000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
175552000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
131487000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
348900000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
160205000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
144008000 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
131823000 usd
us-gaap Cost Of Revenue
CostOfRevenue
285982000 usd
us-gaap Cost Of Revenue
CostOfRevenue
157610000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
31544000 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
-336000 usd
us-gaap Gross Profit
GrossProfit
62918000 usd
us-gaap Gross Profit
GrossProfit
2595000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35140000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20934000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
80679000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52477000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29435000 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16508000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68306000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41007000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
64575000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
37442000 usd
us-gaap Operating Expenses
OperatingExpenses
148985000 usd
us-gaap Operating Expenses
OperatingExpenses
93484000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-33031000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-37778000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-86067000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-90889000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
156000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
236000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
59000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32875000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37771000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-85831000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-90830000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-32875000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-37771000 usd
us-gaap Profit Loss
ProfitLoss
-85831000 usd
us-gaap Profit Loss
ProfitLoss
-90830000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19178000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-37771000 usd
us-gaap Net Income Loss
NetIncomeLoss
-72134000 usd
us-gaap Net Income Loss
NetIncomeLoss
-90830000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-12383000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-12383000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1314000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1314000 usd
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50664146 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50664146 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
0 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50664146 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50664146 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
0 shares
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-32875000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-37771000 usd
us-gaap Profit Loss
ProfitLoss
-85831000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
88400000 usd
us-gaap Profit Loss
ProfitLoss
-90830000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-98000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1024000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-47000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2936000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-32973000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-36747000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-85878000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-87894000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19192000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36747000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-72097000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-87894000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-13187000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-13187000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-594000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-594000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1033208000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1033208000 usd
CY2022Q2 sym Stockholders Equity Accretion Of Temporary Equity
StockholdersEquityAccretionOfTemporaryEquity
4844000 usd
CY2022Q2 sym Stockholders Equity Preferred Return
StockholdersEquityPreferredReturn
6913000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
74280000 usd
CY2022Q2 sym Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
103980000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-19178000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-14000 usd
CY2022Q2 sym Temporary Equity Payments Of Reverse Recapitalization Costs
TemporaryEquityPaymentsOfReverseRecapitalizationCosts
37104000 usd
CY2022Q2 sym Stock Issued During Period Value Reverse Recapitalization And Creation Of Noncontrolling Interest
StockIssuedDuringPeriodValueReverseRecapitalizationAndCreationOfNoncontrollingInterest
551904000 usd
CY2022Q2 sym Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
30315000 usd
CY2022Q2 sym Stock Issued During Period Value Reverse Recapitalization
StockIssuedDuringPeriodValueReverseRecapitalization
421706000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-13697000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-888000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
73128000 usd
CY2021Q1 us-gaap Members Equity
MembersEquity
-911883000 usd
CY2021Q1 us-gaap Members Equity
MembersEquity
-911883000 usd
CY2021Q2 sym Stockholders Equity Accretion Of Temporary Equity
StockholdersEquityAccretionOfTemporaryEquity
53251000 usd
CY2021Q2 sym Stockholders Equity Preferred Return
StockholdersEquityPreferredReturn
8229000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
26999000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-37771000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1024000 usd
CY2021Q2 us-gaap Members Equity
MembersEquity
-983111000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1113228000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1113228000 usd
sym Stockholders Equity Accretion Of Temporary Equity
StockholdersEquityAccretionOfTemporaryEquity
28433000 usd
sym Stockholders Equity Preferred Return
StockholdersEquityPreferredReturn
24195000 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
74280000 usd
sym Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
277776000 usd
us-gaap Profit Loss
ProfitLoss
-72134000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
37000 usd
CY2022Q2 sym Temporary Equity Payments Of Reverse Recapitalization Costs
TemporaryEquityPaymentsOfReverseRecapitalizationCosts
37104000 usd
CY2022Q2 sym Stock Issued During Period Value Reverse Recapitalization And Creation Of Noncontrolling Interest
StockIssuedDuringPeriodValueReverseRecapitalizationAndCreationOfNoncontrollingInterest
551904000 usd
CY2022Q2 sym Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
30315000 usd
CY2022Q2 sym Stock Issued During Period Value Reverse Recapitalization
StockIssuedDuringPeriodValueReverseRecapitalization
421706000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-13697000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-888000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
73128000 usd
CY2020Q3 us-gaap Members Equity
MembersEquity
-844467000 usd
CY2020Q3 us-gaap Members Equity
MembersEquity
-844467000 usd
sym Stockholders Equity Accretion Of Temporary Equity
StockholdersEquityAccretionOfTemporaryEquity
53060000 usd
sym Stockholders Equity Preferred Return
StockholdersEquityPreferredReturn
24689000 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
26999000 usd
us-gaap Profit Loss
ProfitLoss
-90830000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2936000 usd
CY2021Q2 us-gaap Members Equity
MembersEquity
-983111000 usd
us-gaap Profit Loss
ProfitLoss
-85831000 usd
us-gaap Profit Loss
ProfitLoss
-90830000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4200000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3208000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
22000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-47000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-4098000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
50000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
70000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-344000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14533000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
93944000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6592000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
43069000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3110000 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
61000 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-96165000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1603000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-10000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
69091000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7429000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
12741000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6273000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
33674000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
89152000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1990000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
922000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-96729000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
96024000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10769000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5333000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10769000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5333000 usd
us-gaap Proceeds From Issuance Of Common Limited Partners Units
ProceedsFromIssuanceOfCommonLimitedPartnersUnits
384672000 usd
us-gaap Proceeds From Issuance Of Common Limited Partners Units
ProceedsFromIssuanceOfCommonLimitedPartnersUnits
0 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
300000000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
277776000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
362448000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-50000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
255028000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
90641000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
156634000 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58264000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
411662000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148905000 usd
sym Cash Acquired Through Reverse Recapitalization Net Of Redemptions
CashAcquiredThroughReverseRecapitalizationNetOfRedemptions
47021000 usd
CY2022Q2 sym Tax Receivable Agreement Net Cash Savings Percentage
TaxReceivableAgreementNetCashSavingsPercentage
0.85
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Use of Estimates</span></div><div style="margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses, and the amounts disclosed in the related notes to the consolidated financial statements. Actual results and outcomes may differ materially from management’s estimates, judgments, and assumptions. Significant estimates, judgments, and assumptions used in these financial statements include, but are not limited to, those related to revenue, useful lives and realizability of long-lived assets, accounting for income taxes and related valuation allowances, and unit-based compensation. Estimates are periodically reviewed in light of changes in circumstances, facts, and experience. </span></div>The COVID-19 pandemic has resulted in a sustained global slowdown of economic activity that has decreased demand for a broad variety of goods and services, including from our customers. While we have not experienced significant disruptions from the COVID-19 pandemic during the first three quarters of fiscal 2022, we are unable to accurately predict the extent to which the COVID-19 pandemic may impact our business, results of operations, and financial condition going forward. Estimates and assumptions about future events and their effects cannot be determined with certainty and therefore require the exercise of judgment. As of the date of issuance of these financial statements, we are not aware of any specific event or circumstance that would require us to update our estimates, assumptions, and judgments or revise the carrying value of our assets or liabilities. These estimates may change as new events occur and additional information is obtained and will be recognized in the consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to our financial statements.
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.06
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
9040000 shares
sym Reverse Recapitalization Repurchase Of Shares
ReverseRecapitalizationRepurchaseOfShares
300000000 usd
sym Reverse Recapitalization Net
ReverseRecapitalizationNet
84700000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
205000000 usd
sym Cash Acquired Through Reverse Recapitalization
CashAcquiredThroughReverseRecapitalization
200000000 usd
sym Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
30315000 usd
sym Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
421706000 usd
sym Reverse Recapitalization Repurchase Of Shares
ReverseRecapitalizationRepurchaseOfShares
300000000 usd
sym Reverse Recapitalization Proceeds From Issuance Of Common Stock
ReverseRecapitalizationProceedsFromIssuanceOfCommonStock
70000 usd
sym Reverse Recapitalization Transaction Costs
ReverseRecapitalizationTransactionCosts
37104000 usd
sym Reverse Recapitalization Net
ReverseRecapitalizationNet
84672000 usd
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
528441744 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
528441744 shares
CY2022Q2 sym Stock Issued During Period Shares Issued For Working Capital Loan Settlement
StockIssuedDuringPeriodSharesIssuedForWorkingCapitalLoanSettlement
200000 shares
sym Reverse Recapitalization Transaction Costs
ReverseRecapitalizationTransactionCosts
37100000 usd
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
11300000000 usd
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
528441744 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
528441744 shares
CY2022Q2 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
2549000 usd
CY2021Q3 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
63370000 usd
CY2022Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
37274000 usd
CY2021Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
379019000 usd
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
475956000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
305700000 usd
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
117088000 usd
CY2021Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
33065000 usd
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9897000 usd
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
496000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
126985000 usd
CY2021Q3 us-gaap Inventory Net
InventoryNet
33561000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
42858000 usd
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
37177000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22348000 usd
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18560000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20510000 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18617000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
1300000 usd
us-gaap Depreciation
Depreciation
3900000 usd
CY2021Q2 us-gaap Depreciation
Depreciation
1300000 usd
us-gaap Depreciation
Depreciation
2900000 usd
CY2022Q2 sym Tax Receivable Agreement Future Payments
TaxReceivableAgreementFuturePayments
107000000 usd
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
4390000 usd
CY2021Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
0 usd
CY2021Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3735000 usd
CY2020Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
0 usd
CY2022Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1578000 usd
CY2021Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3109000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3590000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3109000 usd
CY2022Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
470000 usd
CY2021Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
237000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1827000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
237000 usd
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
5498000 usd
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2872000 usd
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
5498000 usd
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2872000 usd
CY2022Q2 sym Number Of Classes Of Membership Interests
NumberOfClassesOfMembershipInterests
5 class
CY2022Q2 sym Number Of Classes Of Common Stock
NumberOfClassesOfCommonStock
3 class
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-32875000 usd
us-gaap Profit Loss
ProfitLoss
-85831000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1314000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1314000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50664146 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50664146 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50664146 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50664146 shares
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
131487000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
348900000 usd
CY2022Q2 sym Number Of Distribution Centers
NumberOfDistributionCenters
42 distribution_center
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
175552000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
160205000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20510000 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18617000 usd

Files In Submission

Name View Source Status
0001837240-22-000008-index-headers.html Edgar Link pending
0001837240-22-000008-index.html Edgar Link pending
0001837240-22-000008.txt Edgar Link pending
0001837240-22-000008-xbrl.zip Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sym-20220625.htm Edgar Link pending
sym-20220625.xsd Edgar Link pending
sym-20220625_cal.xml Edgar Link unprocessable
sym-20220625_def.xml Edgar Link unprocessable
sym-20220625_htm.xml Edgar Link completed
sym-20220625_lab.xml Edgar Link unprocessable
sym-20220625_pre.xml Edgar Link unprocessable